Bacterial cyclostatin, or how do bacteria manipulate the eukaryotic cell cycle;Les cyclostatines bactériennes ou comment les bactéries manipulent le cycle cellulaire eucaryote

Medecine/Sciences

Volumn 19, Issue 11, 2003, Pages 1128-1136

  De Rycke, Jean ^a   Ducommun, Bernard ^b  

^a CEMAGREF   (France)

^b Institut d'Exploration Fonctionnelle des Genomes   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BACTERIAL TOXIN; CYCLOSTATIN; CYTOLETHAL DISTENDING TOXIN; UNCLASSIFIED DRUG;

BACTERIUM; CELL CYCLE; CELL PROLIFERATION; CYTOTOXICITY; DNA DAMAGE; EUKARYOTE; MODEL; NONHUMAN; REVIEW; TOXIN ANALYSIS;

BACTERIA (MICROORGANISMS); EUKARYOTA;

EID: 0242497280     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/200319111128     Document Type: Review

References (46)

1. Viallard JF, Lacombe F, Belloc F, Pellegrin JL, Reiffers J. Mécanismes moléculaires contrôlant le cycle cellulaire: aspects fondamentoux et implications en oncologogie. Cancer Radiother 2001; 5: 109-29.
2. Thuret JY, Mann C. Kinases activatrices de la division cellulaire: in vivo veritas? Med Sci 1998; 14: 215-8.
3. Hulleman E, Boonstra J. Regulation of 61 phase progression by growth factors and the extracellular matrix. Cell Mol Life Sci 2001; 58: 80-93.
4. Fishman DD, Segal S, Livneh E. The role of protein kinase C in 61 and G2/M phases of the cell cycle. Int J Oncol 1998; 12: 181-6.
5. Jayadev S, Liu B, Bielawska AE, et al. Role for ceramide in cell cycle arrest. J Biol Chem 1995; 270: 2047-52.
6. Pearce AK, Humphrey TC. Integrating stress-response and cell-cycle checkpoint pathways. Trends Cell Biol 2001; 11: 426-33.
7. Takenaka K, Moriguchi T, Nishida E. Activation of the protein kinase p38 in the spindle assembly checkpoint and mitotic arrest. Science 1998; 280: 599-602.
8. De Rycke J, Oswald E. Cytolethal distending toxin (CDT): a bacterial weapon to control host cell proliferation? FEMS Microbiol Lett 2001; 203: 141-8.
9. Comayras C, Tasca C, Peres SY, Ducommun B, Oswald E, De Rycke J. Escherichia coli cytolethal distending toxin blocks the HeLa cell cycle at the G2/M transition by preventing cdc2 protein kinase dephosphorylation and activation. Infect Immun 1997; 65: 5088-95.
10. Sert V, Cans C, Tasca C, et al. The bacterial cytolethal distending toxin (CDT) triggers a G2 cell cycle checkpoint in mammalian cells without preliminary induction of DNA strand breaks. Oncogene 1999; 18: 6296-304.
11. Escalas N, Davezac N, De Rycke J, Baldin V, Mazars R, Ducommun B. Study of the cytolethal distending toxin-induced cell cycle arrest in HeLa cells: involvement of the CDC25 phosphatase. Exp Cell Res 2000; 257: 206-12.
12. Cortes-Bratti X, Karlsson C, Lagergard T, Thelestam M, Frisan T. The Haemophilus ducreyi cytolethal distending toxin induces cell cycle arrest and apoptosis via the DNA damage checkpoint pathways. J Biol Chem 2001; 276: 5296-302.
13. Alby F, Mazars R, De Rycke J, et al. Study of the cytolethal distending toxin (CDT)-activated cell cycle checkpoint. Involvement of the CHK2 kinase. FEBS Lett 2001; 491: 261-5.
14. Li L, Sharipo A, Chaves-Olarte E, et al. The Haemophilus ducreyi cytolethal distending toxin activates sensors of DNA damage and repair complexes in proliferating and non-proliferating cells. Cell Microbiol 2002; 4: 87-99.
15. Sugai M, Kawamoto T, Peres SY, et al. The cell cycle-specific growth-inhibitory factor produced by Actinobacillus actinomycetemcomitans is a cytolethal distending toxin. Infect Immun 1998; 66: 5008-19.
16. Peres SY, Marches O, Daigle F, et al. A new cytolethal distending toxin (CDT) from Escherichia coli producing CNF2 blocks HeLa cell division in G2/M phase. Mol Microbiol 1997; 24: 1095-107.
17. Pickett CL, Cottle DL, Pesci EC, Bikah G. Cloning, sequencing, and expression of the Escherichia coli cytolethal distending toxin genes. Infect Immun 1994; 62: 1046-51.
18. Scott DA, Kaper JB. Cloning and sequencing of the genes encoding Escherichia coli cytolethal distending toxin. Infect Immun 1994; 62: 244-51.
19. Lewis DA, Stevens MK, Latimer JL, et al. Characterization of Haemophilus ducreyi cdtA, cdtB, and cdtC mutants in in vitro and in vivo systems. Infect Immun 2001; 69: 5626-34.
20. Lara-Tejero M, Galan JE. CdtA, CdtB, and CdtC form a tripartite complex that is required for cytolethal distending toxin activity. Infect Immun 2001; 69: 4358-65.
21. Frisk A, Lebens M, Johansson C, et al. The role of different protein components from the Haemophilus ducreyi cytolethal distending toxin in the generation of cell toxicity. Microb Pathog 2001; 30: 313-24.
22. Deng K, Latimer JL, Lewis DA, Hansen EJ. Investigation of the interaction among the components of the cytolethal distending toxin of Haemophilus ducreyi. Biochem Biophys Res Commun 2001; 285: 609-15.
23. Lara-Tejero M, Galan JE. A bacteriol toxin that controls cell cycle progression as a deoxyribonuclease I-like protein. Science 2000; 290: 354-7.
24. Elwell CA, Dreyfus LA. DNase I homologous residues in CdtB are critical for cytolethal distending toxin-mediated cell cycle arrest. Mol Microbial 2000; 37: 952-63.
25. Elwell C, Chao K, Patel K, Dreyfus L. Escherichia coli CdtB mediates cytolethal distending toxin cell cycle arrest. Infect Immun 2001; 69: 3418-22.
26. Hassane DC, Lee RB, Mendenhall MD, Pickett CL. Cytolethal distending toxin demonstrates genotoxic activity in a yeast model. Infect Immun 2001; 69: 5752-9.
27. Okuda J, Fukumoto M, Takeda Y, Nishibuchi M. Examination of diarrheagenicity of cytolethal distending toxin: suckling mouse response to the products of the cdtABC genes of Shigella dysenteriae. Infect Immun 1997; 65: 428-33.
28. Purdy D, Buswell CM, Hodgson AE, McAlpine K, Henderson I, Leach SA. Characterisation of cytolethal distending toxin (CDT) mutants of Campylobacter jejuni. J Med Microbiol 2000; 49: 473-9.
29. Stevens MK, Latimer JL, Lumbley SR, et al. Characterization of a Haemophilus ducreyi mutant deficient in expression of cytolethal distending toxin. Infect Immun 1999; 67: 3900-8.
30. Young RS, Fortney KR, Gelfanova V, et al. Expression of cytolethal distending toxin and hemolysin is not required for pustule formation by Haemophilus ducreyi in human volunteers. Infect Immun 2001; 69: 1938-42.
31. Barth H, Klingler M, Aktories K, Kinzel V. Clostridium botulinum C2 toxin delays entry into mitosis and activation of p34cdc2 kinase and cdc25-C phosphatase in HeLa cells. Infect Immun 1999; 67: 5083-90.
32. Nougayrede JP, Marches O, Boury M, et al. The long-term cytoskeletal rearrangement induced by rabbit enteropothogenic Eschericia coli is Esp dependent but intimin independent. Mol Microbiol 1999; 31: 19-30.
33. Demuth DR, Savary R, Golub E, Shenker BJ. Identification and analysis of fipA, a Fusobacterium nucleatum immunosuppressive factor gene. Infect Immun 1996; 64: 1335-41.
34. Shenker BJ, Datar S. Fusobacterium nucleatum inhibits human T-cell activation by arresting cells in the mid-G1 phase of the cell cycle. Infect Immun 1995; 63: 4830-6.
35. Yoshida J, Ishibashi T, Nishio M. Growth-inhibitory effect of a streptococcal antitumor glycoprotein on human epidermoid carcinoma A431 cells: involvement of dephosphorylation of epidermal growth factor receptor. Cancer Res 2001; 61: 6151-7.
36. Gutkind JS. The pathways connecting G protein-coupled receptors to the nucleus through divergent mitogen-activated protein kinase cascades. J Biol Chem 1998; 273: 1839-42.
37. Yoshida J, Takamura S, Nishio N. Characterization of a streptococcal antitumor glycoprotein (SAGP). Life Sci 1998; 62: 1043-53.
38. Pitari GM, Di Guglielmo MD, Park J, Schulz S, Waldman SA. Guanylyl cyclase C agonists regulate progression through the cell cycle of human colon carcinoma cells. Proc Natl Acad Sci USA 2001; 98: 7846-51.
39. Van Setten PA, van Hinsbergh VW, Van den Heuvel LP, et al. Verocytotoxin inhibits mitogenesis and protein synthesis in purified human glomerular mesangial cells without affecting cell viability: evidence for two distinct mechanisms. J Am Soc Nephrol 1997; 8: 1877-88.
40. Klapproth JM, Scaletsky IC, McNamara BP, et al. A large toxin from pathogenic Escherichia coli strains that inhibits lymphocyte activation. Infect Immun 2000; 68: 2148-55.
41. Matsui K, Nagano K, Arai T, Hirano I, Aoki T. DNA sequencing of the gene encoding Salmonella typhimurium-derived T-cell inhibitor (STI) and characterization of the gene product, cloned STI. FEMS Immunol Med Microbial 1998; 22: 341-9.
42. Knipp U, Birkholz S, Kaup W, Opferkuch W. Partial characterization of a cell proliferation-inhibiting protein produced by Helicobacter pylori. Infect Immun 1996; 64: 3491-6.
43. Shenker BJ, Vitale L, Slots J. Immunosuppressive effects of Prevotella intermedia on in vitro human lymphocyte activation. Infect Immun 1991; 59: 4583-9.
44. Grana X, Reddy EP. Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene 1995; 11: 211-9.
45. Elledge SJ. Cell cycle checkpoints: preventing an identity crisis. Science 1996; 274: 1664-72.
46. Zhou BB, Elledge SJ. The DNA damage response: putting checkpoints in perspective. Nature 2000; 408: 433-9.